NOVALAR PHARMACEUTICALS INC — Form D

NOVALAR PHARMACEUTICALS INC of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2010-07-23. The offering totals $2.5M, of which $1.0M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2010-07-23
• Form: D
• Accession: 0001130807-10-000002
• Industry: Biotechnology
• Exemptions: 06
• Total offering: $2.5M
• Amount sold: $1.0M
• Remaining: $1.5M
• Investors: 5
• Date of first sale: 2010-07-16
• Security types: debt
• Revenue range: Decline to Disclose
• SEC file number: 021-145399

Issuer

• Name: NOVALAR PHARMACEUTICALS INC
• CIK: 0001130807
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 12555 HIGH BLUFF DRIVE, SUITE 300, SAN DIEGO, CA, 92130
• Phone: 858-436-1100

Officers, directors & promoters (7)

More

• CIK 1130807 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search